Selective drugs versus heterogeneous diagnoses towards a new methodology in psychopharmacologic research

Psiquiatria Biologica

Volumn 7, Issue 4, 1999, Pages 177-189

  Ban, T A ^a  

^a NONE

Author keywords

Modern neuropsychopharmacologic Psychotropic drugs

Indexed keywords

PSYCHOTROPIC AGENT;

DRUG CLASSIFICATION; DRUG RECEPTOR BINDING; HUMAN; MEDICAL RESEARCH; MENTAL DISEASE; PSYCHOPHARMACOLOGY; REVIEW; TREATMENT INDICATION;

EID: 0033304259     PISSN: 01047787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. They used to call it psychiatry
2. Des effets physiologiques de la morphine et leur combination avec ceux de chloroform
3. Prolegomenon to the clinical prerequisite: Psychopharmacology and the classification of mental disorders
4. As I remember
5. Haloperidol and the butyrophenones: The early years
6. The story of lithium
7. Treatment of pulmonary tuberculosis with hydrazine derivatives of isonicotinic acid
8. Reserpine
9. Neuropsychopharmacology
10. Beeinflussung zentraler wirkungen von reserpin und 5-Hydroxytryptamin durch Isonicotinsaurehydrazine
11. Serotonin release as a possible mechanism of reserpine action
12. Serotonin as a mediator of reserpine action in the brain
13. The psychiatric use of isonicotinic acid hydrazide: A case report
14. The psychiatric side effects of iproniazid
15. Iatrogenic psychotic depressive reaction in hypertensive patients
16. The beginning of psychopharmacology. A personal account
17. Limitations of serotonin-releasing activity to those Rauwolfia alkaloids posessing tranquilizing action
18. On the eve of the neurotransmitter era in biological psychiatry
19. The role of independent science in psychopharmacology
20. Interactions between reserpine, chlorpromazine and imipramine
21. Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues
22. Inhibition of uptake of titriated noradrenaline in the intact rat brain by imipramine and structurally related compounds
23. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain
24. The mode of action of psychotropic drugs
25. Function and dysfunction of the basal ganglia
26. Dopamine receptor binding: Differentiation of agonist and antagonist states, with 3H-dopamine and 3H-haloperidol
27. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
28. Novel dopamine receptors half a decade later
29. New players in the 5-HT receptor field; genes and knockout
30. Az antipsichotikumok receptor interakcioja, farmakodinamikaja es klinikai hatasok
31. Identification of a family of muscarinic acetylcholine receptor genes
32. Can brain region-selective dopamine (DA) receptor blockers preferentially act on schizophenic subtypes?
33. Receptor pharmacology of neuroleptics: Relation to clinical effects
34. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro
35. Binding studies with some new neuroleptics at human brain receptors
36. Biological basis of depression and therapeutic relevance
37. Blockade by newly developed antidepressants of biogenic amine upake into rat brain synaptosomes
38. Antidepressants
39. Selection of pharmacological treatment in depressive illness. Current findings within a historical frame of reference
40. Utilisation en therapeutique psychiatrique d'une phenothiazine d'action centrale elective (4560 RP)
41. Drug therapy in schizophrenia: A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital and placebo
42. Treatment of schizophrenic reactions with phenothiazine derivatives
43. Phenothiazine treatment in acute schizophrenia: Effectiveness
44. Uber die behandlung depressives zustande mit einem iminodibenzylderivat (G 22,355)
45. Clinical pharmacology of imipramine and related antidepressant compounds
46. Accion clinica de la imipramina
47. The CPRS-Development and application of a psychiatric rating scale
48. The brief psychiatric rating scale
49. A rating scale for depression
50. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic
51. Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials
52. Maintenance therapy in psychiatry. 1. Asuncion Schizophrenia
53. A quantitative analysis of clinical drug trials for the treatment of affective disorders
54. Efficacy issues with antidepressants
55. Rating depression with a subscale of the CPRS
56. Hypothalamic dysfunction and antidepressant drugs
57. Family history of CSF homovanillic acid pattern during neuroleptic treatment
58. Die behandlung endogener depressionen mit psychopharmaka
59. Selective antidepressants and cerebrospnal fluid
60. Noradrenergic versus serotonergic anti-depressants: Predictors of treatment response
61. Chlorpromazine: A true story by the progress effected by the drug
62. The present status of physical methods of treatment of schizophrenia
63. Predrug behavior as a predictor of response to phenothiazines among schizophrenics
64. Selective drug action related to schizophrenic subtypes. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine)
65. Options for the treatment of negative symptoms of schizophrenia
66. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
67. Atypical antipsychotic drugs
68. Clozapine for the treatment resistant schizophrenic: A double-blind comparison with chlorpromazine
69. The effects of ataraxic drugs on schizophrenic sub-groups related to experimental findings
70. The influence of the tranquilizers on the Leonhard schizophrenic syndromes
71. Clinical pharmacology and Leonhard's classification of endogenous psychoses
72. Is maintenance neuroleptic therapy necessary in shallow hebephrenia?
73. Febrile catatonia sustained by neuroleptics
74. Description and distribution of the subtypes of schizophreriia based on Leonhard's classification
75. Les neuroleptiques et la loi des stades
76. An international survey of tardive dyskinesia
77. Neurotoxicity with combined administraton of lithium and a neuroleptic
78. Die Schichtung des emotionalen Lebens und der Aufbau der depressions zustande